Document Type

Article

Publication Date

7-10-2023

Publication Title

Biology

Keywords

alginate hydrogel, CpG ODN, mangiferin, alveolar bone, regeneration, inflammation, osteoclastogenesis

ISSN

2079-7737

Volume

12

Issue/No.

7

First Page

976

Abstract

The immune system plays an important role in the skeletal system during bone repair and regeneration. The controlled release of biological factors from the immune system could facilitate and optimize the bone remodeling process through the regulation of the activities of bone cells. This study aimed to determine the effect of the controlled delivery of immunomodulatory biologicals on bone regeneration. Immunostimulatory cytosine-phosphate-guanosine oligodeoxynucleotides (CpG ODN) and glucosylxanthone Mangiferin (MAG)-embedded microbeads were incubated with P. gingivalis-challenged splenocytes, or co-cultured with RAW264.7 cells. The effect of CpG ODN/MAG-containing microbeads on bone regeneration was then tested in vivo in a mouse alveolar bone defect model. The results demonstrated that MAG significantly antagonized P. gingivalis proliferation and reduced the live/dead cell ratio. After the addition of CpG ODN + MAG microbeads, anti-inflammatory cytokines IL-10 and IL-4 were upregulated on day 2 but not day 4, whereas proinflammatory cytokine IL-1β responses showed no difference at both timepoints. RANKL production by splenocytes and TRAP+ cell formation of RAW264.7 cells were inhibited by the addition of CpG ODN + MAG microbeads. Alveolar bony defects, filled with CpG ODN + MAG microbeads, showed significantly increased new bone after 4 weeks. In summary, this study evaluated a new hydrogelbased regimen for the local delivery and controlled release of biologicals to repair and regenerate alveolar bony defects. The combined CpG ODN + MAG treatment may promote alveolar bone regeneration through the anti-microbial/anti-inflammatory effects and the inhibition of RANKL-mediated osteoclastogenesis.

Comments

Funding: This research was funded by the National Institutes of Health (NIH) grant number R01DE025255 to X.H., DE027851 to T.K., DE028715 to T.K., and DE029709 to T.K. Forsyth Pilot grant FPILOT 60 to X.H. The APC was funded by NIH.

Institutional Review Board Statement: This study was approved by the Institutional Animal Care and Use Committee (IACUC) of the Forsyth Institute (19-005, 24 May 2019).

Creative Commons License

Creative Commons Attribution 4.0 International License
This work is licensed under a Creative Commons Attribution 4.0 International License.

DOI

10.3390/biology12070976

Peer Reviewed

Included in

Dentistry Commons

Share

COinS